Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rb+ Breast Cancer”

6 trials

Showing 6 of 6 results

Early research (Phase 1)Active Not RecruitingNCT02608216
What this trial is testing

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Who this might be right for
Breast NeoplasmMetastatic Breast CancerRb+ Breast Cancer
University of Pennsylvania 20
Early research (Phase 1)Study completedNCT02599363
What this trial is testing

A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Ended earlyNCT03130439
What this trial is testing

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 27
Early research (Phase 1)WithdrawnNCT05655598
What this trial is testing

TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Who this might be right for
Advanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more
Brown University
Not applicableUnknownNCT01514565
What this trial is testing

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer

Who this might be right for
Breast Cancer
Thomas Jefferson University 70
Early research (Phase 1)Study completedNCT01320592
What this trial is testing

PD0332991/Paclitaxel in Advanced Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 28

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation